Follow
ADARSH KUMAR CHIRANJIVI
ADARSH KUMAR CHIRANJIVI
Postdoctoral Researcher
No verified email
Title
Cited by
Cited by
Year
Identification of an anti–SARS–CoV-2 receptor-binding domain–directed human monoclonal antibody from a naïve semisynthetic library
HA Parray, AK Chiranjivi, S Asthana, N Yadav, T Shrivastava, S Mani, ...
Journal of Biological Chemistry 295 (36), 12814-12821, 2020
592020
Design of commercially comparable nanotherapeutic agent against human disease-causing parasite, Leishmania
A Baranwal, AK Chiranjivi, A Kumar, VK Dubey, P Chandra
Scientific reports 8 (1), 8814, 2018
442018
Non-neutralizing SARS CoV-2 directed polyclonal antibodies demonstrate cross-reactivity with the HA glycans of influenza virus
P Murugavelu, R Perween, T Shrivastava, V Singh, HA Parray, S Singh, ...
International Immunopharmacology 99, 108020, 2021
172021
Severe acute respiratory syndrome coronavirus 2 spike protein based novel epitopes induce potent immune responses in vivo and inhibit viral replication in vitro
P Vishwakarma, N Yadav, ZA Rizvi, NA Khan, AK Chiranjivi, S Mani, ...
Frontiers in immunology 12, 613045, 2021
172021
Antioxidant, anti-tyrosinase and anti-inflammatory activities of 3, 5-dihydroxy-4′, 7-dimethoxyflavone isolated from the leaves of Alpinia nigra
MK Gupta, S Senthilkumar, AK Chiranjivi, K Banik, S Girisa, ...
Phytomedicine Plus 1 (3), 100097, 2021
102021
A broadly neutralizing monoclonal antibody overcomes the mutational landscape of emerging SARS-CoV-2 variants of concern
HA Parray, N Narayanan, S Garg, ZA Rizvi, T Shrivastava, S Kushwaha, ...
PLOS Pathogens 18 (12), e1010994, 2022
82022
The SARS CoV-2 spike directed non-neutralizing polyclonal antibodies cross-react with Human immunodeficiency virus (HIV-1) gp41
R Perween, M PraveenKumar, T Shrivastava, HA Parray, V Singh, ...
International Immunopharmacology 101, 108187, 2021
82021
Dihydrolipoamide dehydrogenase from Leishmania Donovani: new insights through biochemical characterization
AK Chiranjivi, VK Dubey
International journal of biological macromolecules 112, 1241-1247, 2018
82018
Evaluation of CAAX prenyl protease II of Leishmania donovani as potential drug target: Infectivity and growth of the parasite is significantly lowered after the gene knockout
R Bhardwaj, M Das, S Singh, AK Chiranjivi, SV Prabhu, SK Singh, ...
European Journal of Pharmaceutical Sciences 102, 156-160, 2017
82017
A class-mismatched TCR bypasses MHC restriction via an unorthodox but fully functional binding geometry
NK Singh, JA Alonso, JR Devlin, GLJ Keller, GI Gray, AK Chiranjivi, ...
Nature Communications 13 (1), 7189, 2022
62022
BLIMP-1 Mediated Downregulation of TAK1 and p53 Molecules Is Crucial in the Pathogenesis of Kala-Azar
G Saha, AK Chiranjivi, BM Khamar, K Prerna, M Kumar, VK Dubey
Frontiers in Cellular and Infection Microbiology 10, 594431, 2020
52020
Synthesis and characterization of zinc derivatized 3, 5-dihydroxy 4′, 7-dimethoxyflavone and its anti leishmaniasis activity against Leishmania donovani
MK Gupta, AK Chiranjivi, T Dutta, VK Dubey, L Rangan
Biometals 35 (2), 285-301, 2022
32022
Episomal expression of human glutathione reductase (HuGR) in Leishmania sheds light on evolutionary pressure for unique redox metabolism pathway: Impaired stress tolerance …
J Prakash, S Yadav, G Saha, AK Chiranjivi, S Kumar, S Sasidharan, ...
International journal of biological macromolecules 121, 498-507, 2019
32019
Biophysical and Biochemical Characterization of the Receptor Binding Domain of SARS-CoV-2 Variants
R Khatri, HA Parray, G Siddiqui, AK Chiranjivi, S Raj, R Kaul, V Maithil, ...
The Protein Journal 41 (4), 457-467, 2022
12022
Mutational studies on Leishmania donovani dihydrolipoamide dehydrogenase (LdBPK291950. 1) indicates that the enzyme may not be classical class-I pyridine nucleotide-disulfide …
AK Chiranjivi, J Prakash, G Saha, P Chandra, VK Dubey
International Journal of Biological Macromolecules 164, 2141-2150, 2020
12020
Kennedy epitope (KE)-dependent retrograde transport of efficiently cleaved HIV-1 envelopes (Envs) and its effect on Env cell surface expression and viral particle formation
S Das, HA Parray, AK Chiranjivi, P Kumar, A Goswami, M Bansal, ...
The Protein Journal 43 (2), 375-386, 2024
2024
Correction: Kennedy Epitope (KE)-dependent Retrograde Transport of Efficiently Cleaved HIV-1 Envelopes (Envs) and its Effect on Env Cell Surface Expression and Viral Particle …
S Das, HA Parray, AK Chiranjivi, P Kumar, A Goswami, M Bansal, ...
The Protein Journal, 1-6, 2024
2024
Generation of soluble, cleaved, well-ordered, native-like dimers of dengue virus 4 envelope protein ectodomain (sE) suitable for vaccine immunogen design
AK Chiranjivi, D Kumar, R Kumar, HA Parray, S Ahmed, CS Kumar, ...
International Journal of Biological Macromolecules 217, 19-26, 2022
2022
Synthesis and evaluation of methyl 4-(7-hydroxy-4, 4, 8-trimethyl-3-oxabicyclo [3.3. 1] nonan-2-yl) benzoate as an antileishmanial agent and its synergistic effect with …
PB Prachi Bhalla, SS Sabera Sultana, AK Chiranjivi, AK Saikia, VK Dubey
2018
Design of commercially comparable nanotherapeutic agent against human disease-causing parasite, Leishmania.
AB Anupriya Baranwal, AK Chiranjivi, AK Ashutosh Kumar, VK Dubey, ...
2018
The system can't perform the operation now. Try again later.
Articles 1–20